ROCHE ROBERT P JR
Insider CIK 1210193 · ATRS Director · PATH Director · PETX Director · EGLT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 76,548 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 20,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 61,930 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 48,542 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 58,246 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 46,729 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 80,318 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 150,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 99,395 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 118,392 | $5.60 | $663.0K | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 49,425 | $5.60 | $276.8K | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 48,542 | — | $0 | 48,542 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-06-10 | 2021-06-14 | 25,452 | $4.42 | $112.5K | 167,817 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2020-06-11 | 2020-06-15 | 58,246 | — | $0 | 58,246 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2020-06-11 | 2020-06-15 | 30,220 | $2.73 | $82.5K | 142,365 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 20,000 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 10,000 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 7,500 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 7,500 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 7,500 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 7,500 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer | 2019-07-18 | 2019-07-18 | 18,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2019-06-13 | 2019-06-14 | 46,729 | — | $0 | 46,729 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2019-06-13 | 2019-06-14 | 23,973 | $2.92 | $70.0K | 112,145 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2019-06-06 | 2019-06-07 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award | 2019-06-06 | 2019-06-07 | 4,500 | — | $0 | 18,000 | SEC↗ |
| EGLT Egalet Corp | D To issuer deriv | 2019-01-31 | 2019-02-04 | 26,282 | — | $0 | 0 | SEC↗ |
| EGLT Egalet Corp | D To issuer deriv | 2019-01-31 | 2019-02-04 | 75,000 | — | $0 | 0 | SEC↗ |
| EGLT Egalet Corp | D To issuer deriv | 2019-01-31 | 2019-02-04 | 58,133 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2018-07-27 | 2018-07-30 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award | 2018-07-27 | 2018-07-30 | 4,500 | — | $0 | 13,500 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2018-06-08 | 2018-06-11 | 76,548 | — | $0 | 76,548 | SEC↗ |
| EGLT Egalet Corp | A Award deriv | 2018-05-14 | 2018-05-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2017-06-21 | 2017-06-23 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award | 2017-06-21 | 2017-06-23 | 4,500 | — | $0 | 9,000 | SEC↗ |
| EGLT Egalet Corp | A Award deriv | 2017-06-08 | 2017-06-12 | 58,133 | — | $0 | 58,133 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2017-06-07 | 2017-06-09 | 80,318 | — | $0 | 80,318 | SEC↗ |
| EGLT Egalet Corp | A Award deriv | 2017-01-03 | 2017-01-04 | 26,282 | — | $0 | 26,282 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2016-06-24 | 2016-06-28 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award | 2016-06-24 | 2016-06-28 | 4,500 | — | $0 | 4,500 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2016-06-02 | 2016-06-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2016-03-18 | 2016-03-22 | 50,000 | $0.72 | $36.0K | 88,172 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2015-08-24 | 2015-08-25 | 5,000 | $1.77 | $8.8K | 38,172 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2015-08-13 | 2015-08-17 | 5,000 | $1.94 | $9.7K | 33,172 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2015-06-18 | 2015-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2015-05-28 | 2015-06-19 | 99,395 | — | $0 | 99,395 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2014-08-13 | 2014-08-14 | 5,000 | $1.96 | $9.8K | 28,172 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2014-06-23 | 2014-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2014-05-29 | 2014-06-02 | 61,930 | — | $0 | 81,930 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 5,787 | $3.74 | $21.6K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 13,500 | $3.81 | $51.4K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 4,099 | $3.35 | $13.7K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 8,951 | $4.39 | $39.3K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 6,604 | $3.53 | $23.3K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 5,179 | $3.42 | $17.7K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 4,956 | $3.24 | $16.1K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 4,326 | $2.77 | $12.0K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 6,750 | $3.43 | $23.2K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 7,486 | — | $0 | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 6,014 | — | $0 | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 2,024 | — | $0 | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 6,750 | — | $0 | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 2,169 | — | $0 | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 9,050 | $4.78 | $43.3K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 9,955 | $4.96 | $49.4K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2014-02-21 | 2014-02-25 | 4,976 | $3.10 | $15.4K | 0 | SEC↗ |
| PATH NUPATHE INC. | D To issuer | 2014-02-21 | 2014-02-25 | 13,500 | $6.80 | $91.8K | 0 | SEC↗ |
| PATH NUPATHE INC. | U Tender | 2014-02-21 | 2014-02-25 | 10,000 | $6.80 | $68.0K | 0 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2013-12-31 | 2014-01-03 | 6,604 | — | $0 | 6,604 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2013-09-30 | 2013-10-02 | 8,951 | — | $0 | 8,951 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2013-08-09 | 2013-08-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2013-08-09 | 2013-08-12 | 18,172 | — | $0 | 23,172 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2013-06-30 | 2013-07-02 | 5,787 | — | $0 | 5,787 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2013-06-05 | 2013-06-07 | 13,500 | — | $0 | 13,500 | SEC↗ |
| PATH NUPATHE INC. | A Award | 2013-04-24 | 2013-04-29 | 13,500 | — | $0 | 23,500 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2013-03-31 | 2013-04-02 | 4,099 | $2.90 | $11.9K | 4,099 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2012-12-31 | 2013-01-03 | 5,179 | $2.29 | $11.9K | 5,179 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2012-09-30 | 2012-10-01 | 4,956 | $2.40 | $11.9K | 4,956 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2012-06-30 | 2012-07-03 | 4,326 | $2.74 | $11.9K | 4,326 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2012-06-07 | 2012-06-11 | 6,750 | — | $0 | 6,750 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2012-03-31 | 2012-04-03 | 4,976 | $2.39 | $11.9K | 4,976 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2011-12-31 | 2012-01-04 | 9,955 | $1.19 | $11.8K | 9,955 | SEC↗ |